Skip to content
Advertisement

bristol-myers-study.jpeg

FILE - In this June 15 2005 file photo, a sign stands in front of the Bristol-Myers Squibb Company's headquarters in Lawrence Township, N.J.  Bristol-Myers Squibb Co.’s blockbuster cancer treatment Opdivo failed a key study focusing on its use as a lone treatment for lung cancer, prompting a stock plunge, Friday, Aug. 5, 2016. The drug is already approved as a treatment for melanoma, kidney cancer and lung cancer following chemotherapy. (AP Photo/Mel Evans, File)

FILE - In this June 15 2005 file photo, a sign stands in front of the Bristol-Myers Squibb Company's headquarters in Lawrence Township, N.J. Bristol-Myers Squibb Co.’s blockbuster cancer treatment Opdivo failed a key study focusing on its use as a lone treatment for lung cancer, prompting a stock plunge, Friday, Aug. 5, 2016. The drug is already approved as a treatment for melanoma, kidney cancer and lung cancer following chemotherapy. (AP Photo/Mel Evans, File)

Featured Photo Galleries

01-Army parade.png

Military parade celebrates Army’s 250th

Cheers and chants rang out Saturday from a crowd of thousands as soldiers manned modern and historic tanks and aircraft for the Army’s 250th anniversary celebration in the District.

20250330 Sabatini-Caps-Sabres 001.jpg

Ovi scores goal 890, Caps lose to Sabres 8-5

Alexander Ovechkin scored goal number 890, but the Washington Capitals fell short, losing to the visiting Buffalo Sabres Sunday afternoon 8-5 at Capital One Arena in Washington D.C., March 30, 2025 (Photos for the Washington Times.)